CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenues:
Total revenues	$ 118,697	$ 48,118	$ 299,692	$ 116,545
Operating expenses:
Research and development	16,284	12,128	46,287	36,513
Selling, general and administrative	108,633	57,910	296,641	168,280
Total operating expenses	133,226	73,280	362,685	212,693
Loss from operations before other income (expense)	(14,529)	(25,162)	(62,993)	(96,148)
Other income (expense):
Interest income	4,114	4,120	11,797	11,367
Interest expense	(2,268)	(2,445)	(6,721)	(5,537)
Loss on debt extinguishment	0	0	0	(1,944)
Other income (expense), net	98	67	(128)	(179)
Total other income (expense), net	1,944	1,742	4,948	3,707
Net loss	(12,585)	(23,420)	(58,045)	(92,441)
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Unrealized gain (loss) on marketable securities and cash equivalents	250	522	110	348
Comprehensive loss	$ (12,335)	$ (22,898)	$ (57,935)	$ (92,093)
Net loss per share - basic (usd per share)	$ (0.30)	$ (0.61)	$ (1.40)	$ (2.48)
Net loss per share - diluted (usd per share)	$ (0.30)	$ (0.61)	$ (1.40)	$ (2.48)
Weighted-average shares outstanding, basic (in shares)	42,607,717	38,381,968	41,457,027	37,286,911
Weighted-average shares outstanding - diluted (in shares)	42,607,717	38,381,968	41,457,027	37,286,911
Product sales, net
Revenues:
Total revenues	$ 118,697	$ 48,118	$ 299,692	$ 113,651
Operating expenses:
Cost of sales	8,309	3,242	19,757	7,900
License fees and collaboration revenue
Revenues:
Total revenues	$ 0	$ 0	$ 0	$ 2,894